3/30
07:39 pm
meso
First Three Children to Commence Treatment With Ryoncil®
Low
Report
First Three Children to Commence Treatment With Ryoncil®
3/26
08:19 pm
meso
Ryoncil® is Now Available for Purchase in the United States
Medium
Report
Ryoncil® is Now Available for Purchase in the United States
3/13
07:42 pm
meso
Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
Low
Report
Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
3/12
07:30 am
meso
Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
Medium
Report
Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
3/6
06:54 pm
meso
Mesoblast Added to S&P/ASX 200 INDEX
Low
Report
Mesoblast Added to S&P/ASX 200 INDEX
3/5
07:43 am
meso
Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Medium
Report
Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
2/26
05:30 pm
meso
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
Low
Report
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
2/26
11:50 am
meso
Mesoblast Limited (MESO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Low
Report
Mesoblast Limited (MESO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
2/25
06:13 pm
meso
Mesoblast Financial Results and Corporate Update Webcast
Medium
Report
Mesoblast Financial Results and Corporate Update Webcast
2/23
06:33 pm
meso
Dr. Gregory George MD PhD Joins Mesoblast Board
Low
Report
Dr. Gregory George MD PhD Joins Mesoblast Board
2/19
06:00 am
meso
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
Medium
Report
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
2/13
08:07 pm
meso
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings [Yahoo! Finance]
Medium
Report
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings [Yahoo! Finance]
2/13
06:37 pm
meso
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
Medium
Report
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
2/7
10:11 am
meso
Mesoblast Limited (NASDAQ: MESO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $24.00 price target on the stock, up previously from $15.00.
Low
Report
Mesoblast Limited (NASDAQ: MESO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $24.00 price target on the stock, up previously from $15.00.
2/1
05:58 am
meso
Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Low
Report
Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
1/30
07:11 pm
meso
Ryoncil® Commercial Launch Update and Product Pipeline
Medium
Report
Ryoncil® Commercial Launch Update and Product Pipeline
1/30
06:20 pm
meso
Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024
Medium
Report
Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024